(INVX) Innovex International - Overview
Sector: Energy | Industry: Oil & Gas Equipment & Services | Exchange: NYSE (USA) | Market Cap: 2.066m USD | Total Return: 92.4% in 12m
Avg Turnover: 11.2M
Qual. Beats: 0
Rev. Trend: 98.3%
Qual. Beats: 0
Warnings
Fakeout Below Avwap Earnings
Tailwinds
No distinct edge detected
Innovex International, Inc. (INVX) is a Houston-based provider of mission-critical engineered tools and services for the global oil and natural gas industry. The company’s portfolio spans the entire well lifecycle, including drilling enhancement, well construction, completion, and artificial lift production solutions. Their offerings cater to both onshore and offshore applications, providing specialized equipment such as subsea wellheads, liner hanger systems, and downhole fishing tools.
The company operates within the oilfield services sector, a capital-intensive industry where demand is closely correlated with global exploration and production (E&P) spending and rig counts. Innovex utilizes a hybrid business model involving both the direct sale and rental of equipment to national oil companies and independent operators. This rental component allows the company to generate recurring revenue streams while reducing the upfront capital requirements for its clients during drilling and intervention phases.
Investors may find it useful to review detailed financial metrics and valuation trends for INVX on ValueRay. The companys focus on mission-critical components often provides a competitive moat, as these products are essential for maintaining wellbore integrity and optimizing the rate of penetration in complex geological formations.
- Global rig count fluctuations directly impact drilling enhancement tool rental revenue
- Offshore deepwater capital expenditure cycles drive subsea engineered system sales volumes
- Expansion of artificial lift and production services stabilizes recurring cash flow
- Raw material price volatility affects manufacturing margins for well construction products
- International expansion into national oil company markets dictates long-term growth trajectory
| Net Income: 51.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 3.49 > 1.0 |
| NWC/Revenue: 61.95% < 20% (prev 62.96%; Δ -1.01% < -1%) |
| CFO/TA 0.14 > 3% & CFO 179.7m > Net Income 51.9m |
| Net Debt (-124.5m) to EBITDA (205.8m): -0.60 < 3 |
| Current Ratio: 5.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (68.9m) vs 12m ago -0.77% < -2% |
| Gross Margin: 27.05% > 18% (prev 0.34%; Δ 2.67k% > 0.5%) |
| Asset Turnover: 78.66% > 50% (prev 64.65%; Δ 14.01% > 0%) |
| Interest Coverage Ratio: 59.73 > 6 (EBITDA TTM 205.8m / Interest Expense TTM 2.27m) |
| A: 0.47 (Total Current Assets 752.9m - Total Current Liabilities 147.8m) / Total Assets 1.29b |
| B: 0.20 (Retained Earnings 254.5m / Total Assets 1.29b) |
| C: 0.11 (EBIT TTM 135.6m / Avg Total Assets 1.24b) |
| D: 1.02 (Book Value of Equity 261.0m / Total Liabilities 256.8m) |
| Altman-Z'' = 5.53 = AAA |
| DSRI: 0.72 (Receivables 245.6m/269.1m, Revenue 976.9m/773.2m) |
| GMI: 1.24 (GM 27.05% / 33.63%) |
| AQI: 0.94 (AQ_t 0.25 / AQ_t-1 0.27) |
| SGI: 1.26 (Revenue 976.9m / 773.2m) |
| TATA: -0.10 (NI 51.9m - CFO 179.7m) / TA 1.29b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of May 29, 2026, the stock is trading at USD 26.96 with a total of 251,792 shares traded.
Over the past week, the price has changed by -12.92%,
over one month by -4.23%,
over three months by +2.31% and
over the past year by +92.43%.
Innovex International has received a consensus analysts rating of 2.00. Therefore, it is recommended to sell INVX.
- StrongBuy: 0
- Buy: 0
- Hold: 0
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 32.3 | 19.6% |
P/E Trailing = 40.0667
P/S = 2.1152
P/B = 2.0043
Revenue TTM = 976.9m USD
EBIT TTM = 135.6m USD
EBITDA TTM = 205.8m USD
Long Term Debt = 57.4m USD (estimated: total debt 76.2m - short term 18.8m)
Short Term Debt = 18.8m USD (from shortTermDebt, last quarter)
Debt = 76.2m USD (from shortLongTermDebtTotal, last quarter) (leases 76.2m already included)
Net Debt = -124.5m USD (calculated: Debt 76.2m - CCE 200.7m)
Enterprise Value = 1.94b USD (2.07b + Debt 76.2m - CCE 200.7m)
Interest Coverage Ratio = 59.73 (Ebit TTM 135.6m / Interest Expense TTM 2.27m)
EV/FCF = 13.32x (Enterprise Value 1.94b / FCF TTM 145.8m)
FCF Yield = 7.51% (FCF TTM 145.8m / Enterprise Value 1.94b)
FCF Margin = 14.92% (FCF TTM 145.8m / Revenue TTM 976.9m)
Net Margin = 5.31% (Net Income TTM 51.9m / Revenue TTM 976.9m)
Gross Margin = 27.05% ((Revenue TTM 976.9m - Cost of Revenue TTM 712.6m) / Revenue TTM)
Gross Margin QoQ = 28.57% (prev 23.26%)
Tobins Q-Ratio = 1.51 (Enterprise Value 1.94b / Total Assets 1.29b)
Interest Expense / Debt = 2.98% (Interest Expense 2.27m / Debt 76.2m)
Taxrate = 35.19% (45.2m / 128.5m)
NOPAT = 87.9m (EBIT 135.6m * (1 - 35.19%))
Current Ratio = 5.10 (Total Current Assets 752.9m / Total Current Liabilities 147.8m)
Debt / Equity = 0.07 (Debt 76.2m / totalStockholderEquity, last quarter 1.03b)
Debt / EBITDA = -0.60 (Net Debt -124.5m / EBITDA 205.8m)
Debt / FCF = -0.85 (Net Debt -124.5m / FCF TTM 145.8m)
Total Stockholder Equity = 1.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.18% (Net Income 51.9m / Total Assets 1.29b)
RoE = 5.03% (Net Income TTM 51.9m / Total Stockholder Equity 1.03b)
RoCE = 12.46% (EBIT 135.6m / Capital Employed (Equity 1.03b + L.T.Debt 57.4m))
RoIC = 8.62% (NOPAT 87.9m / Invested Capital 1.02b)
WACC = 8.43% (E(2.07b)/V(2.14b) * Re(8.67%) + D(76.2m)/V(2.14b) * Rd(2.98%) * (1-Tc(0.35)))
Discount Rate = 8.67% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 58.43 | Cagr: 14.77%
[DCF] Terminal Value 77.71% ; FCFF base≈124.9m ; Y1≈143.2m ; Y5≈210.8m
[DCF] Fair Price = 47.30 (EV 3.13b - Net Debt -124.5m = Equity 3.25b / Shares 68.8m; r=8.43% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.30 | # QB: 0
Revenue Correlation: 98.25 | Revenue CAGR: 44.58% | SUE: 0.12 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.30 | Chg30d=-1.32% | Revisions=-20% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.36 | Chg30d=-6.41% | Revisions=-20% | Analysts=3
EPS current Year (2026-12-31): EPS=1.34 | Chg30d=-0.17% | Revisions=+0% | GrowthEPS=+27.3% | GrowthRev=+1.9%
EPS next Year (2027-12-31): EPS=1.86 | Chg30d=+7.14% | Revisions=+20% | GrowthEPS=+38.7% | GrowthRev=+7.1%
[Analyst] Revisions Ratio: -20%